Clinical trials
Completed Glucose Metabolism Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Ultragenyx Pharmaceutical Inc | 3 |
| Eli Lilly and Company | 2 |
| Takeda | 2 |
| Akcea Therapeutics | 1 |
| CRISPR Therapeutics AG | 1 |
| Laval University | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Rezolute | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 17 |
| Metabolic Diseases | 12 |
| Diabetes Mellitus | 10 |
| Endocrine System Diseases | 10 |
| Diabetes Mellitus, Type 2 | 9 |
| Diabetes Mellitus, Type 1 | 3 |
| Glycogen Storage Disease Type I | 3 |
| Autoimmune Diseases | 2 |
| Digestive System Diseases | 2 |
| Immune System Diseases | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.